HIF3A and obesity disorder: 4) Three independent studies including ours consistently point to the association of HIF3A promoter hypermethylation with adverse metabolic outcomes such as obesity and insulin resistance, in omentum of gestational diabetes mellitus patients and in human peripheral blood cells analyzed by EWAS (Zhang et al., 2019; Crocker et al., 2020).